217 related articles for article (PubMed ID: 33843962)
1. Buprenorphine Opioid Treatment During the COVID-19 Pandemic.
Luigi M; Luo M; Maes EJP
JAMA Intern Med; 2021 Aug; 181(8):1135. PubMed ID: 33843962
[No Abstract] [Full Text] [Related]
2. Buprenorphine Opioid Treatment During the COVID-19 Pandemic-Reply.
Nguyen TD; Saloner B; Stein BD
JAMA Intern Med; 2021 Aug; 181(8):1135-1136. PubMed ID: 33843947
[No Abstract] [Full Text] [Related]
3. TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
Pena E; Ahmed S
Addiction; 2020 Oct; 115(10):1978-1979. PubMed ID: 32447795
[No Abstract] [Full Text] [Related]
4. Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020.
Chalasani R; Shinabery JM; Goetz CT; Chang CH; Yang Q; Suda KJ; Gellad WF
J Gen Intern Med; 2021 Dec; 36(12):3915-3917. PubMed ID: 34378112
[No Abstract] [Full Text] [Related]
5. Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia.
Roberts J; White B; Attalla D; Ward S; Dunlop AJ
Addiction; 2021 Feb; 116(2):426-427. PubMed ID: 32888226
[No Abstract] [Full Text] [Related]
6. Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic.
Currie JM; Schnell MK; Schwandt H; Zhang J
JAMA Netw Open; 2021 Apr; 4(4):e216147. PubMed ID: 33856474
[TBL] [Abstract][Full Text] [Related]
7. Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic.
Peckham AM; Ball J; Colvard MD; Dadiomov D; Hill LG; Nichols SD; Tallian K; Ventricelli DJ; Tran TH
Am J Health Syst Pharm; 2021 Mar; 78(7):613-618. PubMed ID: 33411894
[TBL] [Abstract][Full Text] [Related]
8. Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report.
Flavin L; Tofighi B; Krawczyk N; Schatz D; McNeely J; Butner J
J Addict Med; 2022 Jan-Feb 01; 16(1):e59-e61. PubMed ID: 35120069
[TBL] [Abstract][Full Text] [Related]
9. A Community Partnership to Improve Access to Buprenorphine in a Homeless Population.
Leo P; Gastala N; Fleurimont J; Messmer S; Maes P; Richardson J; Neeb C; Stackhouse N; Koruba S; Watson DP
Ann Fam Med; 2021; 19(1):85. PubMed ID: 33431401
[No Abstract] [Full Text] [Related]
10. The intertwined expansion of telehealth and buprenorphine access from a prescriber hub.
Moore DT; Wischik DL; Lazar CM; Vassallo GG; Rosen MI
Prev Med; 2021 Nov; 152(Pt 2):106603. PubMed ID: 33974959
[TBL] [Abstract][Full Text] [Related]
11. Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic.
Dadiomov D; Trotzky-Sirr R; Shooshtari A; Qato DM
Drug Alcohol Depend; 2022 Mar; 232():109291. PubMed ID: 35033953
[TBL] [Abstract][Full Text] [Related]
12. Lessons from COVID 19: Are we finally ready to make opioid treatment accessible?
Krawczyk N; Fingerhood MI; Agus D
J Subst Abuse Treat; 2020 Oct; 117():108074. PubMed ID: 32680610
[No Abstract] [Full Text] [Related]
13. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
Cochran G; Bruneau J; Cox N; Gordon AJ
Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
[TBL] [Abstract][Full Text] [Related]
14. Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
Weintraub E; Seneviratne C; Anane J; Coble K; Magidson J; Kattakuzhy S; Greenblatt A; Welsh C; Pappas A; Ross TL; Belcher AM
JAMA Netw Open; 2021 Aug; 4(8):e2118487. PubMed ID: 34448869
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine maintenance treatment in patients with opioid use disorder diagnosed with COVID-19.
Frost M
J Opioid Manag; 2020; 16(6):405-407. PubMed ID: 33428187
[TBL] [Abstract][Full Text] [Related]
16. Use and misuse of opioid agonists in opioid addiction.
Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
[TBL] [Abstract][Full Text] [Related]
17. Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough?
Weimer MB; Wakeman SE; Saitz R
JAMA; 2021 Mar; 325(12):1147-1148. PubMed ID: 33630020
[No Abstract] [Full Text] [Related]
18. The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth.
Cales RH; Cales SC; Shreffler J; Huecker MR
J Subst Abuse Treat; 2022 Feb; 133():108543. PubMed ID: 34210567
[TBL] [Abstract][Full Text] [Related]
19. "How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.
Krawczyk N; Bunting AM; Frank D; Arshonsky J; Gu Y; Friedman SR; Bragg MA
Int J Drug Policy; 2021 Jun; 92():103140. PubMed ID: 33558165
[TBL] [Abstract][Full Text] [Related]
20. Controlling the Swing of the Opioid Pendulum.
Comerci G; Katzman J; Duhigg D
N Engl J Med; 2018 Feb; 378(8):691-693. PubMed ID: 29466151
[No Abstract] [Full Text] [Related]
[Next] [New Search]